Kimia
7 known investors
Kimia develops a drug discovery platform called ATLAS that combines active learning, automated chemical synthesis, high-throughput screening, and machine learning to design and optimize novel drug molecules. The company generates large-scale chemical and biological datasets to map the relationship between chemical structure and protein function for generative drug design.
AI & Machine LearningBiotechDeep Tech
Founders & leadership
SH
Stig HanseninFounder
Investors · 7
Funding
SEC filings, press & company announcements$7M disclosed across 1 of 2 rounds · 2026
- $7MSeedApr 2026 · 3 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Kimia do?
- Kimia develops a drug discovery platform called ATLAS that combines active learning, automated chemical synthesis, high-throughput screening, and machine learning to design and optimize novel drug molecules. The company generates large-scale chemical and biological datasets to map the relationship between chemical structure and protein function for generative drug design.
- Who founded Kimia?
- Kimia was founded by Stig Hansen.
- Who are Kimia's investors?
- Kimia's investors include Horizons Ventures, The Column Group, AirTree Ventures, Blackbird Ventures, DIMENSION, Dimension Capital, Skip Capital.
- How much funding has Kimia raised?
- Kimia has disclosed $7M raised across 1 of its 2 known rounds.